Heartflow, Inc.

Contributing Author

Recent Articles by Heartflow, Inc.

Aug-28	Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half HTFL GlobeNewswire
Aug-27	Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference HTFL GlobeNewswire
Aug-13	Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance HTFL HTFL +35.70% GlobeNewswire
Jul-23	Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026 HTFL GlobeNewswire
Jul-09	New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management HTFL +6.00% GlobeNewswire
May-14	Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance HTFL HTFL -12.17% GlobeNewswire
Apr-23	Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026 HTFL -5.13% GlobeNewswire
Apr-13	Heartflow Files Patent Infringement Lawsuit Against Cleerly HTFL GlobeNewswire
Mar-18	Heartflow Reports Fourth Quarter and Full Year 2025 Financial Results HTFL +13.10% GlobeNewswire
Mar-16	Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning HTFL GlobeNewswire
Feb-18	Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference HTFL +6.33% GlobeNewswire
Feb-13	Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 HTFL -8.14% HTFL +7.79% GlobeNewswire
Feb-12	Heartflow Expands GAMEFILM Registry to NBA and NHL Alumni, Precisely Measuring Heart Disease Risk in Former Professional Athletes HTFL -16.55% GlobeNewswire
Jan-06	Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S. HTFL GlobeNewswire
Jan-05	Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference HTFL GlobeNewswire
Dec-18	Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD HTFL +8.98% HTFL +6.49% GlobeNewswire
Dec-11	Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease HTFL GlobeNewswire
Nov-19	Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference HTFL GlobeNewswire
Nov-12	Heartflow Reports Third Quarter 2025 Financial Results HTFL HTFL -13.43% GlobeNewswire
Nov-09	AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification HTFL GlobeNewswire
Nov-03	Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025 HTFL -8.38% GlobeNewswire
Oct-23	Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025 HTFL HTFL -5.11% GlobeNewswire
Oct-22	New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning HTFL +7.27% GlobeNewswire
Sep-22	Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform HTFL HTFL +14.13% GlobeNewswire
Aug-27	Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference HTFL +10.77% HTFL -7.54% GlobeNewswire
Aug-11	Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares HTFL GlobeNewswire

Heartflow, Inc.

Recent Articles by Heartflow, Inc.

Upgrade your Finviz experience